HilleVax, Inc. (HLVX)
NASDAQ: HLVX · Real-Time Price · USD
2.100
+0.010 (0.48%)
Sep 9, 2025, 12:51 PM - Market open
HilleVax Market Cap
HilleVax has a market cap or net worth of $103.94 million as of September 9, 2025. Its market cap has increased by 8.90% in one year.
Market Cap
103.94M
Enterprise Value
-32.56M
1-Year Change
8.90%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since the IPO on April 29, 2022, HilleVax's market cap has decreased from $538.26M to $103.94M, a decrease of -80.69%. That is a compound annual growth rate of -38.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 103.45M | 3.61% |
| Dec 31, 2024 | 99.85M | -86.63% |
| Dec 29, 2023 | 746.58M | 25.20% |
| Dec 30, 2022 | 596.32M | 10.79% |
| Apr 29, 2022 | 538.26M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |